[HTML][HTML] Competing endogenous RNAs, non-coding RNAs and diseases: an intertwined story
U Ala - Cells, 2020 - mdpi.com
MicroRNAs (miRNAs), a class of small non-coding RNA molecules, are responsible for RNA
silencing and post-transcriptional regulation of gene expression. They can mediate a fine …
silencing and post-transcriptional regulation of gene expression. They can mediate a fine …
[HTML][HTML] The role of LncRNAs in tumor immunotherapy
X Pan, C Li, J Feng - Cancer cell international, 2023 - Springer
Cancer immunotherapy is a major breakthrough in the history of tumor therapy in the last
decade. Immune checkpoint inhibitors blocking CTLA-4/B7 or PD-1/PD-L1 pathways have …
decade. Immune checkpoint inhibitors blocking CTLA-4/B7 or PD-1/PD-L1 pathways have …
Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data
Y Gao, S Shang, S Guo, X Li, H Zhou, H Liu… - Nucleic acids …, 2021 - academic.oup.com
Abstract An updated Lnc2Cancer 3.0 (http://www. bio-bigdata. net/lnc2cancer or http://bio-
bigdata. hrbmu. edu. cn/lnc2cancer) database, which includes comprehensive data on …
bigdata. hrbmu. edu. cn/lnc2cancer) database, which includes comprehensive data on …
Dual targeting of PD-L1 and PD-L2 by PCED1B-AS1 via sponging hsa-miR-194-5p induces immunosuppression in hepatocellular carcinoma
F Fan, K Chen, X Lu, A Li, C Liu, B Wu - Hepatology international, 2021 - Springer
Abstract Background PD-L1 and PD-L2 are PD-1 ligands (PD-Ls). PD-Ls over-expression is
associated with poor prognosis in hepatocellular carcinoma (HCC). However, little is known …
associated with poor prognosis in hepatocellular carcinoma (HCC). However, little is known …
[HTML][HTML] Establishment of a cell necroptosis index to predict prognosis and drug sensitivity for patients with triple-negative breast cancer
J Xie, W Tian, Y Tang, Y Zou, S Zheng, L Wu… - Frontiers in Molecular …, 2022 - frontiersin.org
Background: Necroptosis has been an alternatively identified mechanism of programmed
cancer cell death, which plays a significant role in cancer. However, research about …
cancer cell death, which plays a significant role in cancer. However, research about …
Cellular and molecular regulation of the programmed death-1/programmed death ligand system and its role in multiple sclerosis and other autoimmune diseases
J Ibañez-Vega, C Vilchez, K Jimenez, C Guevara… - Journal of …, 2021 - Elsevier
Abstract Programmed Cell Death 1 (PD-1) receptor and its ligands (PD-Ls) are essential to
maintain peripheral immune tolerance and to avoid tissue damage. Consequently, altered …
maintain peripheral immune tolerance and to avoid tissue damage. Consequently, altered …
Long non-coding RNA HCP5 in cancer
Y Zou, B Chen - Clinica chimica acta, 2021 - Elsevier
Cancer remains a major threat to human health worldwide. Long non-coding RNA (lncRNA)
comprises a group of single-stranded RNA with lengths longer than 200 bp. LncRNAs are …
comprises a group of single-stranded RNA with lengths longer than 200 bp. LncRNAs are …
[HTML][HTML] Identifying immune checkpoint-related lncRNA biomarkers for immunotherapy response and prognosis in cancers
Y Gao, X Wang, L Dong, C Qu, Q Lu, P Wang, M Xin… - Scientific Data, 2023 - nature.com
Long non-coding RNAs (lncRNAs) could modulate expression of immune checkpoints
(ICPs) in tumor-immune. However, precise functions in immunity and potential for predicting …
(ICPs) in tumor-immune. However, precise functions in immunity and potential for predicting …
[HTML][HTML] Development of a novel immune-related lncRNA signature as a prognostic classifier for endometrial carcinoma
J Liu, J Mei, Y Wang, X Chen, J Pan… - … journal of biological …, 2021 - ncbi.nlm.nih.gov
Endometrial carcinoma (EnCa) is one of the deadliest gynecological malignancies. The
purpose of the current study was to develop an immune-related lncRNA prognostic …
purpose of the current study was to develop an immune-related lncRNA prognostic …
[HTML][HTML] Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes
Breast cancer is a heterogeneous disease classified into four main subtypes with different
clinical outcomes, such as patient survival, prognosis, and relapse. Current genetic tests for …
clinical outcomes, such as patient survival, prognosis, and relapse. Current genetic tests for …